NDC Active Ingredient Bortezomib
Active Ingredient Information
What is Bortezomib?
A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.
What is the usage for Bortezomib?
This medication is used to treat certain types of cancer (such as multiple myeloma, mantle cell lymphoma). It works by slowing or stopping the growth of cancer cells.
How many products in the NDC database contain Bortezomib?
The NDC database has 29 products with the active ingredient Bortezomib. The following table lists all the products that have this active ingredient.
NDC Products with Bortezomib
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0143-9098 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Hikma Pharmaceuticals Usa Inc. | ACTIVE | |
0409-1700 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Hospira, Inc. | ACTIVE | |
0409-1703 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Hospira, Inc. | ACTIVE | |
0409-1704 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Hospira, Inc. | ACTIVE | |
0781-3258 | Proprietary Name: Bortezomib | Bortezomib For Injection | Injection, Powder, Lyophilized, For Solution | Intravenous | Sandoz Inc | ACTIVE | |
10019-991 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Baxter Healthcare Corporation | ACTIVE | |
25021-244 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Sagent Pharmaceuticals | ACTIVE | |
43598-426 | Proprietary Name: Bortezomib | Bortexomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Dr.reddy's Laboratories, Inc. | ACTIVE | |
43598-865 | Proprietary Name: Bortezomib | Bortexomib | Injection, Powder, Lyophilized, For Solution | Intravenous | Dr.reddy's Laboratories Inc | ACTIVE | |
50742-484 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Ingenus Pharmaceuticals, Llc | ACTIVE | |
51817-586 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Pharmascience Inc. | ACTIVE | |
55150-337 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Auromedics Pharma Llc | ACTIVE | |
60505-6050 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Apotex Corp | ACTIVE | |
63020-049 | Proprietary Name: Velcade | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Takeda Pharmaceuticals America, Inc. | ACTIVE | |
63323-721 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous | Fresenius Kabi Usa, Llc | ACTIVE | |
63323-821 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Fresenius Kabi Usa, Llc | ACTIVE | |
67184-0530 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Qilu Pharmaceutical Co., Ltd. | ACTIVE | |
68001-534 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Bluepoint Laboratories | ACTIVE | |
68001-540 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Bluepoint Laboratories | ACTIVE | |
68001-541 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Bluepoint Laboratories | ACTIVE | |
70511-161 | Proprietary Name: Bortezomib | Bortezomib | Injection | Intravenous | Maia Pharmaceuticals, Inc. | ACTIVE | |
70511-162 | Proprietary Name: Bortezomib | Bortezomib | Injection | Intravenous | Maia Pharmaceuticals, Inc. | ACTIVE | |
70710-1411 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Zydus Pharmaceuticals Usa Inc. | ACTIVE | |
70771-1708 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Zydus Lifesciences Limited | ACTIVE | |
70860-225 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Athenex Pharmaceutical Division, Llc. | ACTIVE | |
71288-118 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Meitheal Pharmaceuticals Inc. | ACTIVE | |
72205-183 | Proprietary Name: Bortezomib | Bortezomib | Injection, Powder, Lyophilized, For Solution | Intravenous; Subcutaneous | Novadoz Pharmaceuticals Llc | ACTIVE | |
72266-243 | Proprietary Name: Bortezomib | Bortezomib | Injection | Intravenous | Fosun Pharma Usa Inc | ACTIVE | |
72266-244 | Proprietary Name: Bortezomib | Bortezomib | Injection | Intravenous | Fosun Pharma Usa Inc | ACTIVE |